Refine by
Clinical Sample Articles & Analysis
21 news found
The service provides a comprehensive overview of all viral genetic material present in a sample, enabling the detection of both known and previously unknown viruses in a single assay. The Viral Metagenomic Sequencing service is designed to accommodate various sample types, including clinical samples, environmental ...
“We now regard the industrialization of microsphere products as the main development goal and offer microsphere products at a production scale that can be scaled up linearly. The batch size of key clinical study samples should be consistent with the commercial production batch size,” said the Marketing Director of CD Formulation. ...
To see video, please click here In this free webinar you will learn about: Guide to Sample Size Re-estimation in Clinical Trials Unblinded Sample Size Re-estimation Sample Size for Complex Endpoints Sample Size for Win Ratio Statistic Sample Size for Win Ratio Statistic Block ...
ByStatsol
About the webinar We explore common challenges faced when designing and conducting clinical trials with sample size re-estimation (SSR). Common SSR methods are explored along with their pros and cons. ...
ByStatsol
About the webinar In this webinar, we explored some of the issues faced when statistical power is used as the sole metric for trial success when conducting a sample size determination. We showed how Bayesian assurance can be used as a complementary metric, that allows parameter uncertainty to be formally incorporated into the trial design. ...
ByStatsol
Specific Diagnostics today announced formation of its US commercial sales, service, support and marketing teams in anticipation of the launch of the Reveal Rapid AST System for blood infection samples. Following 11 studies across France and England comprising over 1,400 clinical positive blood culture samples, yielding overall accuracy of 97.8%, ...
Concurrently, INOVIO has initiated pre-clinical development of an Omicron-specific DNA vaccine candidate and will progress if needed. ...
Comparing the differential changes in the expression of a large number of proteins in different normal and tumor samples or samples under different treatment conditions. 2. Large-scale analysis of post-translational modification sites in proteins and the changes in protein modification levels under different conditions. 3. ...
In Europe, where the Reveal is launched under CE-IVD registration, 11 studies across France and England comprising over 1,400 clinical positive blood culture samples, yielding overall accuracy of 97.6% have been completed, with 4 of these studies now reported by submitted abstracts, complementing the similar results reported by Henry Ford Health System in ...
The team at Indee Labs has already demonstrated revolutionary improvements over existing methods including scalability, high yield, negligible perturbation of the immune cell state along with rapid processing of research-, clinical- and commercial-scale samples with a simple workflow and a small footprint. ...
The microchip-based test kit was validated using clinical samples from St. Paul’s Hospital in Vancouver, collected during the first coronavirus wave in the spring of 2020. ...
With the newly signed agreement, SAGA will utilize its proprietary ultrasensitive SAGAsafe assays for detection of a panel of mutations in EGFR and other genes and perform analyses on several hundred clinical tissue samples from the Cancer Research UK-funded UCL-sponsored TRACERx* and PEACE** studies. ...
Indee Labs today announced the addition of three of the largest pharmaceutical companies, multiple biotechnology companies as well as Stanford's Cell Therapy Clinic and Moffitt Cancer Center, to participate in its Early Access Program. ...
We’re excited to be supported by the NCI to develop our novel, non-viral gene delivery system called the µVS Delivery SystemTM to insert transgenes for CAR-T and TCR-T cell products at clinical scale at a fraction of the cost of the current approaches using viruses with improved T cell function relative to electroporation. ...
Ventzi Hristova, senior scientist, dynamic omics, antibody discovery and protein engineering, R&D at AstraZeneca, said, "Powered by technological innovation, omics is proving to be one of the richest sources of data in all of science. Clinical proteomics is an emerging field aimed at improving patient care through the development of sensitive, high-throughput methods for ...
Selfdiagnostics SARS-CoV-2 IgM/IgG Antibody Assay Kit has already been widely tested. In studies with clinical samples, it showed 99% specificity and cross-reactivity tests excluded false-positive results with previous endemic human coronavirus antibodies (HKU1, OC43, NL63 and 229E). ...
"As the pathway to precision medicine advances in the lab, reliable and routine analytical workflows will be essential to quantify targeted and untargeted proteins and peptides in clinical samples with greater ease and sensitivity," said Bradley Hart, senior director, clinical marketing, chromatography and mass spectrometry, Thermo Fisher ...
The poster describes results from a clinical sample trial performed with Drs. Mary Jane Ferraro and Virginia Pierce of the Massachusetts General Hospital. Polymicrobial Sample Quantification and Differentiation with Mass Spectrometry Sunday, Jun. 23, 2019; Presentation Time: 11 am-1 pm; CPHM-878; Presenter, Selux Diagnostics, Kristin Baker, ...
Metadata template Introduces a new metadata template specific to Newborn Screening data collection. Clinical Sample Login Upon submission of a Newborn Screening specimen, the system compares the NBS collection device item ID to the Inventory Item's External Identifying Number and provides alerts to the user of collection devices that may not have originated from ...
On Monday, Sept. 1, a scientific symposium titled "Current Challenges in Breast Cancer Diagnosis: New Guidelines and Implementation in Clinical Practice" will be held from 1 p.m. - 2:30 p.m. in Capital Suite Room 7/12. Topics will include: Implementation of guidelines in clinical practice - the EU experience (Dr. Ian Ellis Nottingham, U.K.) ...